Page last updated: 2024-08-17

quinoxalines and pik 75

quinoxalines has been researched along with pik 75 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horiguchi, M; Motomura, T; Oiso, Y; Sakai, H; Yamashita, C	1

Other Studies

1 other study(ies) available for quinoxalines and pik 75

Article	Year
Pulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regeneration. Journal of controlled release : official journal of the Controlled Release Society, 2015, Sep-10, Volume: 213 Topics: Androstadienes; Animals; Cell Differentiation; Cell Line; Humans; Hydrazones; Lung; Male; Mice, Inbred ICR; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Pulmonary Alveoli; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Regeneration; Stem Cells; Sulfonamides; Thiazolidinediones; Wortmannin	2015

Article

Year

Pulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regeneration.

Journal of controlled release : official journal of the Controlled Release Society, 2015, Sep-10, Volume: 213

Topics: Androstadienes; Animals; Cell Differentiation; Cell Line; Humans; Hydrazones; Lung; Male; Mice, Inbred ICR; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Pulmonary Alveoli; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Regeneration; Stem Cells; Sulfonamides; Thiazolidinediones; Wortmannin

2015